The development of asymmetric conjugate addition reactions for C–C bond formation remains an important challenge in organic synthesis.1,2 Much recent work has focused on organocatalytic Michael addition of carbonyl compounds to nitroalkenes.3–5 Among these reactions, Michael addition of aldehydes to nitroalkenes is of particular interest because of the valuable synthetic intermediates that are generated.4 β-Aryl nitroalkenes have been the most common Michael acceptors for reactions developed by other research groups.3–5 These Michael reactions provide α,β-disubstituted-γ-nitrobutanals. Our attention was drawn to nitroethylene as a Michael acceptor because the adducts would bear a single substituent adjacent to the carbonyl and could be readily converted to γ2-amino acids. γ2-Amino acids represent potential building blocks for γ-peptide6 and heterogeneous backbone foldamers.7 In addition, derivatives of the neurotransmitter γ-amino butyric acid (GABA)8 are of potential biomedical utility, as illustrated by the use of Pregabalin and Baclofen to treat neurological disorders.9
The preparation of enantiomerically pure γ-amino acids is challenging, and this synthetic burden has limited the study of γ-peptide foldamers to date. A variety of routes to enantioenriched γ2-amino acids have been described,10 but these approaches often involve specialized chiral auxiliaries and may not be ideal for preparing multigram quantities of protected γ2-amino acids bearing diverse side chain functionality, which is necessary for foldamer research.6,7 Here we report an asymmetric organocatalytic method for aminoethylation of aldehydes, which leads to a new and efficient synthesis of γ2-amino acids (Scheme 1). Our approach pairs a chiral pyrrolidine catalyst with a carefully chosen acidic co-catalyst to promote Michael addition of aldehydes to nitroethylene with high enantioselectivity.
Scheme 1.
We initially evaluated two widely used chiral pyrrolidines, L-proline and (S)-diphenylprolinol silyl ether (A),11 for the ability to promote the Michael reaction between n-pentanal and nitroethylene (2:1 molar ratio). We assumed that such reactions would proceed via enamine intermediates. L-Proline (20 mol %) provided very little of the Michael adduct; instead the major product in a variety of solvents resulted from aldol condensation of n-pentanal, a process that is known to be catalyzed by proline.12 In contrast, when 20 mol % of A was employed in toluene, the desired Michael adduct was generated in 95% yield with >95% ee, and little or no aldol product was formed.

Previous work has shown that carefully chosen acidic co-catalysts can enhance pyrrolidine-or imidazolidinone-catalyzed Michael addition of aldehydes to enones,13 and we therefore examined co-catalyst effects14 on the Michael addition of n-pentanal to nitroethylene. When 5 mol % of A was employed as catalyst, without any co-catalyst, <10% Michael adduct was generated after 1 h, and little further adduct was generated after 24 h (Table 1). However, use of 5 mol % of A along with 200 mol % of acetic acid gave a 95% yield of the Michael adduct after 24 h with excellent stereoselectivity (>95% ee).15 These observations suggest that the role of the acidic component may be to facilitate catalyst turnover and/or to prevent catalyst deactivation pathways.
Table 1.
Organocatalyzed Michael Reaction
| ||||
|---|---|---|---|---|
| entry | catalyst | co-catalyst | yieldb (%) | eec |
| 1 | 20 mol % | none | 95 | >95% |
| 2 | 5 mol % | none | <10 | n.d.d |
| 3a | 5 mol % | HOAc (200 mol %) | 95 | >95% |
| 4 | 2 mol % | HOAc (20 mol %) | 30 | n.d.d |
| 5 | 2 mol % | TFA (20 mol %) | 8 | n.d.d |
| 6a | 2 mol % | HOAc (200 mol %) | 55 | n.d.d |
| 7 | 2 mol % | B (5 mol %) | 96 | >95% |
HOAc used as solvent.
From 1H NMR of the crude reaction mixture.
Determined by a 1H NMR ee assay.16
Not determined.
Many pyrrolidine-catalyzed processes require relatively high levels of catalyst (10–20 mol %). Use of 2 mol % of A with 20 mol % of acetic acid led to a substantial decline in efficiency (30% Michael adduct; Table 1). Switching to a more acidic co-catalyst, trifluoroacetic acid (20 mol %), caused a decrease in yield (8% Michael adduct). Increasing the amount of acetic acid to 200 mol % led to only a modest improvement (55% Michael adduct). Evaluation of a number of other potential acidic co-catalysts identified 3-nitrobenzoic acid (B) as particularly effective: combining 2 mol % of pyrrolidine A with 5 mol % of B provided the Michael adduct in 96% yield with >95% ee.
Having established A + B as an effective catalyst/co-catalyst pair for enantioselective Michael reaction of n-pentanal, we next investigated the scope for the aldehyde substrate (Table 2). These reactions were carried out with 2 mol % of A and 20 mol % of B at 3 °C. Enantioselectivity was determined in most cases after reduction of the initial aldehyde product to the corresponding β-substituted-δ-nitrobutanol derivative. This approach enabled ee determination via HPLC because aldehyde reduction eliminates the possibility of epimerization. As initially observed for n-pentanal, a variety of aldehydes with hydrocarbon appendages give excellent yields and enantioselectivities. Even a β-branched substrate, 3-methylbutanal, can be employed, although elevated temperature (23 °C) is required to achieve full conversion (Table 2, entry 3). Our long-term interest in using γ-amino acids to construct biologically active foldamers17 will require access to examples that bear appropriately protected functional groups in the side chain. Entries 9–11 of Table 2 show that our catalytic Michael addition method enables incorporation of side chains corresponding to those of glutamic acid, tyrosine, and lysine into γ2-amino acid precursors, with excellent yields and enantioselectivities.
Table 2.
Highly Efficient and Enantioselective Michael Reaction of Aldehydes with Nitroethylene
| |||||
|---|---|---|---|---|---|
| entry | product | R | t (h) | yielda (%) | eeb (%) |
| 1 | 2a | Me | 48 | 95 | 98 |
| 2 | 2b | Et | 48 | 96 | 98 |
| 3 | 2cc,d | i-Pr | 32 | 94 | 97 |
| 4 | 2d | n-Bu | 48 | 95 | 99 |
| 5 | 2e | i-Bu | 54 | 94 | >99 |
| 6 | 2f | Bn | 32 | 93 | 99 |
| 7 | 2gc | CH2-c-Hex | 48 | 93 | >99 |
| 8 | 2hc | CH2COOMe | 54 | 92 | 96 |
| 9 | 2i | (CH2)2COOtBu | 54 | 94 | 97 |
| 10 | 2j | 4-OtBuC6H4CH2 | 32 | 94 | 98 |
| 11 | 2k | (CH2)4N(Boc)2 | 48 | 92 | 98 |
Isoated yield.
Determined by chiral HPLC analysis.
Determined by chiral HPLC analysis on the corresponding aldehyde.
At 23 °C.
We used compound 2b, prepared on a 10 mmol scale reaction, to show that the β-substituted-δ-nitrobutanol derivatives generated via the Michael addition/reduction sequence could be converted in a straightforward manner to appropriately protected, enantioenriched γ2-amino acids (Scheme 2). Jones oxidation of 2b provided the γ-nitro-α-alkylbutyric acid 3, which was then transformed to protected γ2-amino acid 4 in an efficient one-pot operation involving nitro group reduction followed by Boc protection. The absolute configuration of 2b was determined as (R) by the X-ray structure analysis of the L-phenylalanine derivative 5 (Scheme 3), and other β-substituted-δ-nitrobutanol configurations were assigned by analogy. The enantiomeric excess of 3 and 4 was measured by 1H NMR after coupling of these acids to L- and D-phenylalanine methyl ester. The short synthetic route in Scheme 2 provides a high overall yield (62% from nitroethylene) and is operationally simple.
Scheme 2.
Scheme 3.
Incorporation of γ-amino acid residues into a growing peptide chain can be difficult because of cyclization side reactions. For example, carbodiimide-mediated coupling of Boc-protected γ2-amino acid 4 (30 mM) to L-phenylalanine methyl ester provides only 13% yield of the desired amide; the major product under these conditions is the N-Boc γ-lactam derived from 4 (69%; Scheme 3). However, the analogous reaction with γ-nitro acid 3, under identical conditions, gives the desired amide in 88% yield. The nitro group can be subsequently reduced via hydrogenation and protected. Thus, γ-nitro acids such as 3, intermediates in our synthetic route, are valuable building blocks for γ-peptide synthesis, with the nitro group serving as a protected amino group.
The highly enantioselective Michael additions reported here constitute a method for formal aminoethylation of aldehydes. The reaction is catalyzed by a chiral pyrrolidine, and relatively low catalyst loading is possible if a carboxylic acid co-catalyst is used. When coupled with subsequent aldehyde reduction, this process provides β-substituted-δ-nitrobutanol derivatives, which are potentially valuable chiral intermediates. We have shown that such intermediates can be converted expeditiously to protected γ2-amino acids, which are interesting as foldamer building blocks. Relatively few methods have been previously described for γ2-amino acid synthesis,10 and these approaches might be challenging to apply to examples featuring diverse side chain functionality. Mechanistic studies regarding the role of acid co-catalyst and the catalytic pathway are in progress.18
Supplementary Material
Acknowledgments
This research was supported by NSF (CHE055190). Y.C. was supported in part by a fellowship from Abbott Laboratories. NMR spectrometers were purchased with partial support from NIH and NSF, and X-ray equipment by NSF. We thank Dr. Ilia Guzei for X-ray structure analysis, and Prof. H. Wennemers for sharing unpublished results.
Footnotes
Supporting Information Available: Experimental procedures and compound characterizations. This material is available free of charge via the Internet at http://pubs.acs.org.
References
- 1.Perlmutter P. Conjugate Addition Reactions in Organic Synthesis. Pergamon Press; Oxford: 1992. [Google Scholar]
- 2.For recent reviews, see: Jarvo ER, Miller SJ. Tetrahedron. 2002;58:2481.Sibi MP, Manyem S. Tetrahedron. 2000;56:8033.Yamaguchi M. In: Comprehensive Asymmetric Catalysis I–III. Jacobsen EN, Pfaltz A, Yamamoto H, editors. Chapter 31.2 Springer-Verlag; Berlin-Heidelberg, Germany: 1999.
- 3.For recent reviews, see: Berner OM, Tedeschi L, Enders D. Eur J Org Chem. 2002. p. 1877.Pellissier H. Tetrahedron. 2007;63:9267.Santanu M, Yang JW, Hoffmann S, List B. Chem Rev. 2007;107:5471. doi: 10.1021/cr0684016.
- 4.For selected examples, see: Betancort JM, Barbas CF., III Org Lett. 2001;3:3737. doi: 10.1021/ol0167006.Mase N, Thayumanavan R, Tanaka F, Barbas CF., III Org Lett. 2004;6:2527. doi: 10.1021/ol049196o.Mase N, Watanabe K, Yoda H, Takabe K, Tanaka F, Barbas CF., III J Am Chem Soc. 2006;128:4966. doi: 10.1021/ja060338e.Wang W, Wang J, Li H. Angew Chem, Int Ed. 2005;44:1369. doi: 10.1002/anie.200461959.Hayashi Y, Gotoh H, Hayashi T, Shoji M. Angew Chem, Int Ed. 2005;44:4212. doi: 10.1002/anie.200500599.Lalonde MP, Chen YG, Jacobsen EN. Angew Chem, Int Ed. 2005;45:6366. doi: 10.1002/anie.200602221.Wiesner M, Revell JD, Wennemers H. Angew Chem, Int Ed. 2008;47:1871. doi: 10.1002/anie.200704972.
- 5.For selected examples, see: List B, Pojarliev P, Martin HJ. Org Lett. 2001;3:2423. doi: 10.1021/ol015799d.Okino T, Hoashi Y, Takemoto Y. J Am Chem Soc. 2003;125:12672. doi: 10.1021/ja036972z.Xu Y, Córdova A. Chem Commun. 2006:460. doi: 10.1039/b514783m.
- 6.(a) Hanessian S, Luo X, Schaum R, Michnick S. J Am Chem Soc. 1998;120:8569. [Google Scholar]; (b) Hintermann T, Gademann K, Jaun B, Seebach D. Helv Chim Acta. 1998;81:983. [Google Scholar]; (c) Woll MG, Lai JR, Guzei IA, Taylor SJC, Smith MEB, Gellman SH. J Am Chem Soc. 2001;123:11077. doi: 10.1021/ja011719p. [DOI] [PubMed] [Google Scholar]; (d) Seebach D, Brenner M, Rueping M, Jaun B. Chem Eur J. 2002;8:573. doi: 10.1002/1521-3765(20020201)8:3<573::AID-CHEM573>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
- 7.(a) Hayen A, Schmitt MA, Ngassa FN, Thomasson KA, Gellman SH. Angew Chem, Int Ed. 2004;43:505. doi: 10.1002/anie.200352125. [DOI] [PubMed] [Google Scholar]; (b) Hagihara M, Anthony NJ, Stout TJ, Clardy J, Schreiber SL. J Am Chem Soc. 1992;114:6568. [Google Scholar]; (c) Vasudev PG, Ananda K, Chatterjee S, Aravinda S, Shamala N, Balaram P. J Am Chem Soc. 2007;129:4039. doi: 10.1021/ja068910p. [DOI] [PubMed] [Google Scholar]
- 8.Johnston GAR. Pharmacol Ther. 1996;69:173. doi: 10.1016/0163-7258(95)02043-8. [DOI] [PubMed] [Google Scholar]
- 9.For selected references, see: Bryans JS, Wustrow DJ. Med Res Rev. 1999;19:149. doi: 10.1002/(sici)1098-1128(199903)19:2<149::aid-med3>3.0.co;2-b.Sammins GL, Jacobsen EN. J Am Chem Soc. 2003;125:4442. doi: 10.1021/ja034635k.Poe SL, Kobaslija M, McQuade TD. J Am Chem Soc. 2007;129:9216. doi: 10.1021/ja071706x.Zu LS, Xie HX, Li H, Wang J, Wang W. Adv Synth Catal. 2007;349:2660.
- 10.Ordóñez M, Cativiela C. Tetrahedron: Asymmetry. 2007;18:3. doi: 10.1016/j.tetasy.2009.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Marigo M, Wabnitz TC, Fielenbach D, Jørgensen KA. Angew Chem, Int Ed. 2005;44:794. doi: 10.1002/anie.200462101. [DOI] [PubMed] [Google Scholar]
- 12.(a) Córdova A, Notz W, Barbas CF., III J Org Chem. 2002;67:301. doi: 10.1021/jo015881m. [DOI] [PubMed] [Google Scholar]; (b) Northrup AB, MacMillan DWC. J Am Chem Soc. 2002;124:6798. doi: 10.1021/ja0262378. [DOI] [PubMed] [Google Scholar]; (c) List B. Tetrahedron. 2002;58:5573. [Google Scholar]
- 13.(a) Melchiorre P, Jørgensen KA. J Org Chem. 2003;68:4151. doi: 10.1021/jo026837p. [DOI] [PubMed] [Google Scholar]; (b) Peelen TJ, Chi Y, Gellman SH. J Am Chem Soc. 2005;127:11598. doi: 10.1021/ja0532584. [DOI] [PubMed] [Google Scholar]; (c) Chi Y, Gellman SH. Org Lett. 2005;7:4253. doi: 10.1021/ol0517729. [DOI] [PubMed] [Google Scholar]
- 14.For a review on co-catalyst effects, see: Vogl EM, Gröger H, Shibasaki M. Angew Chem, Int Ed. 1999;38:1570. doi: 10.1002/(SICI)1521-3773(19990601)38:11<1570::AID-ANIE1570>3.0.CO;2-Y.For selected examples, see: Shi M, Jiang JK, Li CQ. Tetrahedron Lett. 2002;43:127.Aroyan CE, Vasbinder MM, Miller SJ. Org Lett. 2005;7:3849. doi: 10.1021/ol0513544.
- 15.No apparent change on enantioselectivity was observed with the use of the acidic co-catalysts.
- 16.Chi Y, Peelen TJ, Gellman SH. Org Lett. 2005;7:3469. doi: 10.1021/ol051174u. [DOI] [PubMed] [Google Scholar]
- 17.(a) Goodman CM, Choi S, Shandler S, DeGrado WF. Nat Chem Biol. 2007;3:252. doi: 10.1038/nchembio876. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Seebach D, Schaeffer L, Brenner M, Hoyer D. Angew Chem, Int Ed. 2003;42:776. doi: 10.1002/anie.200390205. [DOI] [PubMed] [Google Scholar]
- 18.For related work, see: Wiesner M, Revell JD, Tonazzi S, Wennemers H. J Am Chem Soc. 2008;130:5610. doi: 10.1021/ja801027s.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



